Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

steatorrhea/obesitat

L'enllaç es desa al porta-retalls
Pàgina 1 des de 34 resultats

Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE We determined the effect of dietary fat and oxalate on fecal fat excretion and urine parameters in a rat model of Roux-en-Y gastric bypass surgery. METHODS Diet induced obese Sprague-Dawley® rats underwent sham surgery as controls (16), or Roux-en-Y gastric bypass surgery (19). After

Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Hyperoxaluria after Roux-en-Y gastric bypass (RYGB) is generally attributed to fat malabsorption. If hyperoxaluria is indeed caused by fat malabsorption, magnitudes of hyperoxaluria and steatorrhea should correlate. Severely obese patients, prior to bypass, ingest excess dietary fat that can produce

Assessment of jejunoileostomy for obesity--some observations since 1976.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
In this review, which only partially covers the data available, it is pointed out that the evaluation of the results of jejunoileostomy may depend upon the criteria used by the observers, and disclosure of the true effects of the operation may depend upon the long-term follow-up of the patients.

[Prevalence of anal diseases after Scopinaro's biliopancreatic bypass for super-obese patients].

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND Biliopancreatic diversion by Scopinaro (BD) is a mixed (malabsortive and restrictive) bariatric technique that is successful in achieving long lasting weight lost in super obese patients. In fact, the diarrhoea (steatorrhea) that is expected after any malabsortive technique can sometimes

The effects of loperamide on continence problems and anorectal function in obese subjects taking orlistat.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Continence problems during treatment with orlistat (a lipase inhibitor) are caused when susceptible patients are exposed to increased volumes of loose, fatty stool. OBJECTIVE To investigate the dose-response effects of loperamide on continence and anorectal function in subjects susceptible to

Enteropeptidase: a gene associated with a starvation human phenotype and a novel target for obesity treatment.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND Obesity research focuses essentially on gene targets associated with the obese phenotype. None of these targets have yet provided a viable drug therapy. Focusing instead on genes that are involved in energy absorption and that are associated with a "human starvation phenotype", we have

Drug treatment of the overweight patient.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Three medications with approval for long-term use in the treatment of obesity are currently available in the United States. Sibutramine (U.S. Food and Drug Administration [FDA] approved in 1997), orlistat (FDA approved in 1999), and rimonabant (available in Europe and given FDA approvable status in

Comparision of Efficacy and Safety of Orlistat vs Placebo in Obese Patients in Pakistan

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Introduction Obesity has become a rising health concern in Pakistan. Several primary measures, such as dietary restrictions and regular exercise, are taken to limit the severe consequences of obesity. Still, such measures alone have been proven to be often short term and therefore, inadequate. In

Deficiency of fat soluble vitamins after jejunoileal bypass surgery for morbid obesity.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Significant vitamin A, E, or 25-hydroxy D deficiency occurred in 76% of 40 patients studied up to 6 years after jejunoileal bypass surgery for morbid obesity. Vitamin A was significantly lower in those who had lost 30% of their initial weight than in those who had lost less weight; however, there

The Mechanism of Weight Loss after Ileo-gastrostomy for Morbid Obesity.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Twelve patients (weight 107-178 kg and age range 19-43 years) were investigated following ileo-gastrostomy for morbid obesity. A number of variables were studied prospectively, pre- and postoperatively, to determine the cause of weight loss-previously attributed to malabsorption or decreased caloric

The mechanistic basis of hyperoxaluria following gastric bypass in obese rats.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Roux-en-Y gastric bypass (RYGB) surgery is a popular and extremely effective procedure for sustained weight loss in the morbidly obese. However, hyperoxaluria and oxalate kidney stones frequently develop after RYGB and steatorrhea has been speculated to play a role. We examined the effects of RYGB

Cetilistat for the treatment of obesity.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Obesity is a modern plague in industrialized and developing countries, and currently overweight and obesity cause more deaths worldwide than underweight. Cetilistat is a novel, orally active, gastrointestinal and pancreatic lipase inhibitor. In in vitro studies cetilistat inhibited human pancreatic

[Effectiveness and complications of bariatric surgery in the treatment of morbid obesity].

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
OBJECTIVE Bariatric surgery represents an affective therapeutic alternative for patients with morbid obesity refractory to medical treatment. However, these surgical techniques increase the risk of producing a protein-energy hyponutrition or a selective deficit of some micronutrient. The aim of this

Drug interventions for the treatment of obesity in children and adolescents.

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
Child and adolescent obesity has increased globally, and can be associated with significant short- and long-term health consequences. To assess the efficacy of drug interventions for the treatment of obesity in children and adolescents. We searched CENTRAL, MEDLINE, Embase, PubMed (subsets not
Green-plant thylakoids increase satiety by affecting appetite hormones such as ghrelin, cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1). The objective of this study was to investigate if thylakoids also affect gastrointestinal (GI) passage and microbial composition. To analyse the effects
Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge